Tweet This

Risk Adjustment

Increasing or decreasing payments as the expected spending or level of care needed changes.

Biosimilars User Fee Act

Creates an abbreviated licensure pathway for biologic products that are demonstrated to be “biosimilar” to or “interchangeable” with an FDA-licensed biologic product. This pathway is…